fusidic acid has been researched along with diethylstilbestrol in 2 studies
Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (diethylstilbestrol) | Trials (diethylstilbestrol) | Recent Studies (post-2010) (diethylstilbestrol) |
---|---|---|---|---|---|
1,742 | 117 | 344 | 8,585 | 322 | 491 |
Protein | Taxonomy | fusidic acid (IC50) | diethylstilbestrol (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 12.5893 | |
Estrogen receptor | Homo sapiens (human) | 0.1312 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.67 | |
Adenosine receptor A3 | Homo sapiens (human) | 2.208 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.963 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
Substance-K receptor | Homo sapiens (human) | 9.553 | |
D(1A) dopamine receptor | Homo sapiens (human) | 7.763 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 5.6 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.67 | |
Thromboxane-A synthase | Homo sapiens (human) | 4.359 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 4.79 | |
Adenosine receptor A2a | Homo sapiens (human) | 9.013 | |
Adenosine receptor A1 | Homo sapiens (human) | 2.856 | |
Mu-type opioid receptor | Homo sapiens (human) | 5.778 | |
D(3) dopamine receptor | Homo sapiens (human) | 8.796 | |
Delta-type opioid receptor | Homo sapiens (human) | 2.718 | |
Kappa-type opioid receptor | Homo sapiens (human) | 4.563 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.14 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 2.208 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.071 | |
Aldehyde oxidase | Homo sapiens (human) | 0.46 | |
Estrogen receptor beta | Homo sapiens (human) | 0.1588 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
2 other study(ies) available for fusidic acid and diethylstilbestrol
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |